Section 4: Clinical Pharmacy Services 2021
DOI: 10.1136/ejhpharm-2021-eahpconf.153
|View full text |Cite
|
Sign up to set email alerts
|

4CPS-321 Anakinra in severe COVID-19 pneumonia: retrospective study

Abstract: Conclusion and relevance mHeart has been demonstrated to improve recipients' adherence to IS (85% IG vs 46% CG), patients' experience of therapeutic regimens and to reduce inclinic facilities because of the mHeart follow-up. Innovative research projects on health institutions are typically short lived practices with lack of scalability to usual care. This was a priority for the mHeart study, and the intervention was extended into clinical practice in January 2019.

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles